Experienced in Spontaneous Coronary Artery Dissection (SCAD)

Dirk Sibbing

Munich, BY, DE 
Experienced in Spontaneous Coronary Artery Dissection (SCAD)
Munich, BY, DE 
OverviewLocationsClinical Research

Overview

Dirk Sibbing practices in Munich, Germany. Mr. Sibbing is rated as an Experienced expert by MediFind in the treatment of Spontaneous Coronary Artery Dissection (SCAD). His top areas of expertise are Acute Coronary Syndrome, Coronary Heart Disease, Heart Attack, Percutaneous Coronary Intervention (PCI), and Stent Placement.

His clinical research consists of co-authoring 183 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Spontaneous Coronary Artery Dissection (SCAD).

Gender
Male

Locations

Munich, BY, Germany
Other Locations
Iffeldorf, BY, Germany
Seeshaupt, BY 82402, Germany
Greifswald, MV 17475, Germany
Wuppertal, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multicentre, Randomized, Double-blind, Prospective Investigation on the Effects of Immunoadsorption on Cardiac Function in Patients With Dilated Cardiomyopathy
Multicentre, Randomized, Double-blind, Prospective Investigation on the Effects of Immunoadsorption on Cardiac Function in Patients With Dilated Cardiomyopathy
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
Revacept, a Novel Inhibitor of Platelet Adhesion in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Interventions: a Phase II, Multicentre, Randomised, Double-blind and Placebo-controlled Study
Revacept, a Novel Inhibitor of Platelet Adhesion in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Interventions: a Phase II, Multicentre, Randomised, Double-blind and Placebo-controlled Study
Enrollment Status: Completed
Publish Date: April 20, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

183 Total Publications

Dual antiplatelet therapy modulation strategies beyond standard of care: a promising path towards individualized antiplatelet treatment.
Dual antiplatelet therapy modulation strategies beyond standard of care: a promising path towards individualized antiplatelet treatment.
Journal: European heart journal
Published: August 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sibbing's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 11 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile